Skip to main content

Headline Roundup May 7th, 2025

FDA Appoints COVID Response Critic Dr. Vinay Prasad to Oversee Vaccine Program

Summary from the AllSides News Team

The US Food and Drug Administration (FDA) has selected Dr. Vinay Prasad, who was critical of some COVID-19 public health measures, to lead its program on vaccines and biological drugs.

The Details: Prasad is a professor at the University of California San Francisco who has also made a name for himself as a writer on Substack and commentator on X. Prasad criticized government responses to COVID and questioned whether young males should receive the shot due to showing a higher rate of myocarditis, but called the COVID shot itself “a miraculous, life-saving advance.”

For Context: The FDA falls under the jurisdiction of Health Secretary Robert F. Kennedy Jr., who has been an outspoken critic of several vaccines and other drugs in the past. Prasad’s appointment was announced to staff by FDA head Dr. Marty Makary, and he replaces Dr. Peter Marks, who helped lead the program for 13 years. Prasad has previously criticized Marks in his writings, calling him “anti-data” and “a bobblehead doll that just stamps approval.”

Key Quotes: Marks said, “It has become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.” Makary reportedly wrote, “(Prasad) brings a great set of skills, energy, and competence to the FDA and I know that he is eager to begin immersing himself in the important work of CBER and the agency as a whole.”

How The Media Covered It: Some outlets, like Newsweek (Center bias) and Axios (Lean Left), framed the pick as the choice of Kennedy. CNN (Lean Left) and Washington Examiner (Lean Right) noted that biotech stocks were down significantly after the announcement.

Written by the AllSides staff (of humans). Learn moreSupport our mission. Suggest an improvement to this summary.

Featured Coverage of this Story

From the Left
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division
FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

Marvin Joseph/The Washington Post/Getty Images/File

News

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

Prasad, a professor at the University of California San Francisco, became a harsh critic of the government’s response and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation Warp Speed effort to rapidly develop Covid-19 vaccines and treatments.

Open on CNN Digital
From the Center
Who Is Vinay Prasad? RFK Jr. Taps Pharma Critic to Lead FDA Vaccine Program
News

Dr. Vinay Prasad, a known critic of both the pharmaceutical industry and the Food and Drug Administration, has been appointed to lead the FDA's program overseeing vaccines and biotechnology drugs.

FDA Commissioner Dr. Marty Makary announced the decision in a message to staff on Tuesday, lauding Prasad's "long and distinguished history in medicine." The FDA falls under the guidance of Health Secretary Robert F. Kennedy Jr.

Open on Newsweek
Possible Paywall
From the Right
COVID-19 booster critic tapped to lead FDA vaccine program
News

Agency commissioner Dr. Marty Makary announced Tuesday that Dr. Vinay Prasad, a prominent COVID–19 vaccine critic, has been appointed to lead the Food and Drug Administration Center, which oversees the approval of vaccines and other biologics products.

Prasad, currently a physician-scientist and professor at the University of California, San Francisco, gained a following during the pandemic for criticizing mask mandates, lockdowns, and COVID-19 vaccine boosters. 

Open on Washington Examiner
Possible Paywall

More headline roundups

More News about Public Health on AllSides

News from the Left

News from the Center

News from the Right